Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

New study in Nature Computational Science

Characterizing emerging companies in computational drug development
29.02.2024

The joint study with Duke University on "Characterizing emerging companies in computational drug development" has been published in Nature Computational Science. The following people contributed: Chloe Markey and Samuel Croset as first authors, supported by Olivia Woolley Meza and Dr. Can Martin Buldun-Gora as second authors, as well as Christian Koch, Daniel Koller and Daniel Reker as last authors.
 
The analysis focuses on how companies are accelerating, de-risking and optimizing the drug development process through the use of new algorithms, proprietary data processing and/or hardware improvements. In this highly complex and competitive industry, our study highlights trends and opportunities, identifies high-risk areas and explores underrepresented niches of high value.